4//SEC Filing
Dulac Edward J III 4
Accession 0000950170-24-008803
CIK 0001434316other
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 4:01 PM ET
Size
4.6 KB
Accession
0000950170-24-008803
Insider Transaction Report
Form 4
Dulac Edward J III
Chief Financial Officer
Transactions
- Sale
Common Stock
2024-01-29$5.00/sh−1,849$9,245→ 103,926 total
Footnotes (1)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 5, 2023.
Documents
Issuer
FATE THERAPEUTICS INC
CIK 0001434316
Entity typeother
Related Parties
1- filerCIK 0001821530
Filing Metadata
- Form type
- 4
- Filed
- Jan 29, 7:00 PM ET
- Accepted
- Jan 30, 4:01 PM ET
- Size
- 4.6 KB